Home / Inspections / 1262514

FDA Inspection 1262514 — AmerisourceBergen Drug Corporation

AmerisourceBergen Drug Corporation — FEI 3002533877

The FDA completed an inspection of AmerisourceBergen Drug Corporation on February 27, 2025 in Denver, CO. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
February 27, 2025
Fiscal Year
2025
Product Type
Food/Cosmetics
Project Area
Food Composition, Standards, Labeling and Econ
Location
Denver, CO (United States)

Facility

Other inspections at this facility

  • 1041611 (NAI Tue Jan 16 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 669085 (NAI Fri Jun 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 547213 (NAI Fri Nov 14 2008 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources